43417-5 |
Observation |
Prid |
Esophageal brush |
Pt |
Nom |
Cyto stain |
|
ACTIVE |
Microscopic observation [Identifier] in Esophageal brushing by Cyto stain |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CYTO |
|
43417-5 |
|
Cyto stain |
|
|
Both |
|
|
|
0 |
Cyto Esoph Brush |
|
|
|
N |
|
CYTOLOGY; Cytology stain; Cytostain; Esoph Brush; Esophagial brush; Identity or presence; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; St; Stains; Stn |
2.78 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Updated to seperate the component from the method; |
0 |
43418-3 |
Stem cell product given |
Vol |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Stem cell product given [Volume] |
|
MIN |
DefinitionDescription |
|
|
mL |
|
|
|
|
|
|
BLDBK |
|
43418-3 |
|
|
|
|
Observation |
|
|
|
0 |
Stem Cell Prod Gvn Vol |
|
|
|
N |
|
BLOOD BANK; Gvn; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume |
2.7 |
2.17 |
|
|
|
|
|
|
|
mL |
|
|
|
0 |
43419-1 |
Tuberculosis reaction wheal^3D post 1 TU ID |
Diam |
Skin |
Pt |
Qn |
|
|
ACTIVE |
Tuberculosis reaction wheal [Diameter] --3 days post 1 TU intradermal |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
CHALSKIN |
|
43419-1 |
|
|
|
|
Observation |
|
|
|
0 |
TB Wheal 3D p 1 TU Diam |
|
|
|
N |
|
1st strength PPD; 3D p 1 TU; After; Dermatologic; Diameter; Epidermis; i; Identifier; Integument; Intradermal; Point in time; PPD; PST; Purified protein derivative skin test; Purified protein derivative test; QNT; Quan; Quant; Quantitative; Random; React; Rx wheal; Rxn; Skin test; SKIN TESTS; Skn; TB; TB skin test; TB Wheal; TST; Tubeculin Units |
2.73 |
2.17 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
4342-2 |
Nalbuphine |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Nalbuphine [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4342-2 |
|
|
|
|
Observation |
|
|
|
0 |
Nalbuphine Dose |
|
|
|
Y |
|
Addiction; Dose med or substance; DRUG DOSES; Drugs of abuse; Illicit; Nubain; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
43420-9 |
Uranium dose assessment |
Imp |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Uranium dose assessment [Interpretation] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
43420-9 |
|
|
|
|
Observation |
|
|
|
0 |
Uranium Dose Assessment Ur-Imp |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; U; UA; UR; Urn |
2.19 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
43421-7 |
Thiopurine methyltransferase |
CCnt |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Thiopurine methyltransferase [Enzymatic activity/mass] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
pmol/h/mg Hb |
|
|
|
|
|
|
CHEM |
|
43421-7 |
|
|
|
|
Both |
|
|
|
0 |
TPMT RBC-cCnt |
|
|
|
N |
|
Catalytic Content; Chemistry; Erythrocytes; Methyl transferase; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TPMT |
2.73 |
2.17 |
|
|
|
|
|
|
|
pmol/h/mg{Hb} |
|
|
|
0 |
43422-5 |
Rabbit dander Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Rabbit dander IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
43422-5 |
|
|
|
|
Both |
|
|
|
0 |
Rabbit Dander IgE Qn |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f213; Immune globulin E; Immunoglobulin E; Oryctalagus spp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.7 |
2.17 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
43423-3 |
Sodium urate |
SatFr |
Urine |
24H |
Qn |
|
|
ACTIVE |
Sodium urate [Saturation Fraction] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
43423-3 |
|
|
|
|
Observation |
|
|
|
0 |
Na Urate 24h SatFr Ur |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Kidney; Monosodium Urate; Na; Na Urate; Na+; NaU; Nephrology; Percent; QNT; Quan; Quant; Quantitative; Relative Supersaturation; Renal; RS; Saturation Fraction; UA; UR; Urates; Uric acid; Urn |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
43424-1 |
Bartonella sp Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella sp IgM Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
43424-1 |
|
|
|
|
Both |
|
|
|
0 |
Bartonella IgM Titr CSF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; Rochalimaea species; SmQn; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Titer; Titered; Titre; Ttr |
2.75 |
2.17 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
43425-8 |
Bartonella sp Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella sp IgG Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
43425-8 |
|
|
|
|
Both |
|
|
|
0 |
Bartonella IgG Titr CSF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; Rochalimaea species; SmQn; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Titer; Titered; Titre; Ttr |
2.75 |
2.17 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
43426-6 |
Bacteria |
Prid |
Nph |
Pt |
Nom |
Aerobic culture |
|
ACTIVE |
Bacteria identified in Nasopharynx by Aerobe culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
43426-6 |
|
Aerobic culture |
|
|
Both |
|
|
|
0 |
Bacteria Nph Aerobe Cult |
|
|
|
N |
|
Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nasopharynx; Nominal; Point in time; Random |
2.78 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
43427-4 |
Observation |
Prid |
Tiss |
Pt |
Nom |
Rapid stain |
|
ACTIVE |
Microscopic observation [Identifier] in Tissue by Rapid stain |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
43427-4 |
|
Rapid stain |
|
|
Both |
|
|
|
0 |
Rapid Stn Tiss |
|
|
|
N |
|
Diff-Quick; Identity or presence; Nominal; Pathology; Point in time; Random; Rapid Stn; St; Stains; Stn; Tissue; Tissue, unspecified |
2.78 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Updated to seperate the component from the method; |
0 |
43428-2 |
Bilirubin.microscopic observation |
Prid |
Tiss |
Pt |
Nom |
Hall's stain |
|
ACTIVE |
Bilirubin.microscopic observation [Identifier] in Tissue by Hall's stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
43428-2 |
|
Hall's stain |
|
|
Both |
|
|
|
0 |
Bilirubin Tiss Hall's Stn |
|
|
|
N |
|
Bili; Bilirubins; Billirubin; Hall's Stn; Identity or presence; Nominal; Pathology; Point in time; Random; S prime; St; Stains; Stn; TBIL; Tissue; Tissue, unspecified |
2.22 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
43429-0 |
Haemophilus influenzae B Ag |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Haemophilus influenzae B Ag [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
43429-0 |
|
|
|
|
Both |
|
|
|
0 |
Haem influ B Ag Ser Ql |
|
|
|
N |
|
Antigen; Antigens; H flu; H influenza; H influenzae; Haem influ; Haem influ B; Haemoph; HIB; ID; Infectious Disease; InfectiousDisease; Influ; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
4343-0 |
Nalorphine |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Nalorphine [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4343-0 |
|
|
|
|
Observation |
|
|
|
0 |
Nalorphine Dose |
|
|
|
Y |
|
Addiction; Corgard; Cotzide; Dose med or substance; DRUG DOSES; Drugs of abuse; Illicit; Nalline; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
43430-8 |
Neisseria meningitidis serogroup B Ag |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Neisseria meningitidis serogroup B Ag [Presence] in Serum |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
43430-8 |
|
|
|
|
Both |
|
|
|
0 |
N men sg B Ag Ser Ql |
|
|
|
N |
|
Antigen; Antigens; Group B; ID; Infectious Disease; InfectiousDisease; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N men serogroup; N men sg B; N men sg B Ag; N menigitidis; N meningitidis; Neisseria meningitidis group B; Neisseria meningitidis type B; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.64 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. Added 'serogroup' to the Component for clarification. |
0 |
43431-6 |
Escherichia coli K1 Ag |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Escherichia coli K1 Ag [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
43431-6 |
|
|
|
|
Both |
|
|
|
0 |
E coli K1 Ag Ser Ql |
|
|
|
N |
|
Antigen; Antigens; E coli; E coli K1; ID; Infectious Disease; InfectiousDisease; Microbiology; o002; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43432-4 |
Escherichia coli K1 Ag |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Escherichia coli K1 Ag [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
43432-4 |
|
|
|
|
Both |
|
|
|
0 |
E coli K1 Ag Ur Ql |
|
|
|
N |
|
Antigen; Antigens; E coli; E coli K1; ID; Infectious Disease; InfectiousDisease; Microbiology; o002; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43433-2 |
Acylcarnitine panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Acylcarnitine panel - Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
43433-2 |
|
|
|
|
Order |
|
|
|
0 |
Acylcarnitine Pnl SerPl |
|
|
|
N |
|
Acyl carnitine; Acylcarni; Acylcarnitine Pnl; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.17 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
43434-0 |
Bacterial Ag panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Bacterial Ag panel - Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
43434-0 |
|
|
|
|
Order |
|
|
|
0 |
Bacterial Ag Pnl Ser |
|
|
|
N |
|
Bact; Bacterial Ag Pnl; ID; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR |
2.73 |
2.17 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
43435-7 |
Bartonella henselae & Bartonella quintana Ab.IgM panel |
- |
CSF |
Pt |
- |
|
|
ACTIVE |
Bartonella henselae and Bartonella quintana IgM panel - Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
43435-7 |
|
|
|
|
Order |
|
|
|
0 |
B henselae+quintana IgM Pnl CSF |
|
|
|
N |
|
B henselae; B henselae+quintana IgM Pnl; B quintana; Bacillary angiomaosis; Bacillary pelliosis; Cat Scratch Disease; Cat Scratch Fever; Cerebral spinal fluid; Cerebrospinal Fl; CSD; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; R henselae; R quintana; Random; Rochalimae quintana; Rochalimaea henselae; Rochalimaea quintana; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Trench fever |
2.44 |
2.17 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
43436-5 |
Bartonella henselae & Bartonella quintana Ab.IgG panel |
- |
CSF |
Pt |
- |
|
|
ACTIVE |
Bartonella henselae and Bartonella quintana IgG panel - Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
43436-5 |
|
|
|
|
Order |
|
|
|
0 |
B henselae+quintana IgG Pnl CSF |
|
|
|
N |
|
B henselae; B henselae+quintana IgG Pnl; B quintana; Bacillary angiomaosis; Bacillary pelliosis; Cat Scratch Disease; Cat Scratch Fever; Cerebral spinal fluid; Cerebrospinal Fl; CSD; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; R henselae; R quintana; Random; Rochalimae quintana; Rochalimaea henselae; Rochalimaea quintana; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Trench fever |
2.44 |
2.17 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
43437-3 |
Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel |
- |
CSF |
Pt |
- |
|
|
ACTIVE |
Bartonella henselae and Bartonella quintana IgG and IgM panel - Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
43437-3 |
|
|
|
|
Order |
|
|
|
0 |
B henselae+quintana IgG+IgM Pnl CSF |
|
|
|
N |
|
B henselae; B henselae+quintana IgG+IgM Pnl; B quintana; Bacillary angiomaosis; Bacillary pelliosis; Cat Scratch Disease; Cat Scratch Fever; Cerebral spinal fluid; Cerebrospinal Fl; CSD; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; R henselae; R quintana; Random; Rochalimae quintana; Rochalimaea henselae; Rochalimaea quintana; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Trench fever |
2.44 |
2.17 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
43438-1 |
Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Bartonella henselae and Bartonella quintana IgG and IgM panel - Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
43438-1 |
|
|
|
|
Order |
|
|
|
0 |
B henselae+quintana IgG+IgM Pnl Ser |
|
|
|
N |
|
B henselae; B henselae+quintana IgG+IgM Pnl; B quintana; Bacillary angiomaosis; Bacillary pelliosis; Cat Scratch Disease; Cat Scratch Fever; CSD; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; R henselae; R quintana; Random; Rochalimae quintana; Rochalimaea henselae; Rochalimaea quintana; Serum; SR; Trench fever |
2.73 |
2.17 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
43439-9 |
Bartonella henselae & Bartonella quintana Ab.IgG panel |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella henselae and Bartonella quintana IgG panel [Titer] - Serum |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
43439-9 |
|
|
|
|
Order |
|
|
|
0 |
B henselae+quintana IgG Pnl Titr Ser |
|
|
|
N |
|
B henselae; B henselae+quintana IgG Pnl; B quintana; Bacillary angiomaosis; Bacillary pelliosis; Cat Scratch Disease; Cat Scratch Fever; CSD; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; R henselae; R quintana; Random; Rochalimae quintana; Rochalimaea henselae; Rochalimaea quintana; Serum; SmQn; SR; Titer; Titered; Titre; Trench fever; Ttr |
2.75 |
2.17 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |